Pediatric chewable amoxicillin-clavulanate tablets receive CDSCO nod for dental infections

Chewable tablets combining amoxicillin 250 mg and clavulanate potassium 125 mg indicated for pediatric odontogenic infections; recommended dose 25–45 mg/kg/day divided every 12 hours; cleared by CDSCO in June 2024; marketed nationwide in India; improves compliance in children with dental abscesses and periapical infections.